Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, Massachusetts
- Most recent report
- 8-K, filed Sep 1, 2026
- Incorporated
- Delaware
- Filings on record
- 128 filings
- On EDGAR
- CIK 2022626
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8
News 8 of 16
Prospectuses and Registrations 8
- 424B5 Prospectus supplement for an offering Mar 26, 2026
- S-8 Registration statement for an employee plan Mar 26, 2026
- S-3ASR Automatic shelf registration Nov 5, 2025
- S-8 Registration statement for an employee plan Mar 12, 2025
- S-8 Registration statement for an employee plan Oct 11, 2024
- 424B4 Final prospectus for an offering Oct 11, 2024
- S-1/A Registration statement for an offering, amended Oct 7, 2024
- S-1 Registration statement for an offering Sep 18, 2024
Proxies 4
Ownership 8 of 72
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 12, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 30, 2026
- 4 Insider reported a trade Jun 17, 2026
- 4 Insider reported a trade Jun 17, 2026
- 4 Insider reported a trade Jun 17, 2026
- 4 Insider reported a trade Jun 17, 2026
- 4 Insider reported a trade Jun 17, 2026
- 4 Insider reported a trade Jun 11, 2026
Other 8 of 20
- ARS Annual report sent to shareholders Apr 16, 2026
- ARS Annual report sent to shareholders Apr 17, 2025
- SEC STAFF LETTER Oct 16, 2024
- EFFECT Notice that a registration became effective Oct 10, 2024
- S-1MEF Oct 10, 2024
- CERT Exchange certified a listing Oct 10, 2024
- 8-A12B Registration of a security for exchange listing Oct 8, 2024
- CORRESP Reply to SEC staff Oct 8, 2024
Everything here comes from Upstream Bio, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.